Articles
12 December 2024
Enhancing AAV production with transcriptomics-informed pharmacology
Recombinant adeno-associated virus (rAAV) is a widely used viral vector for gene therapy. However, these vectors have limited availability...
Read More11 December 2024
Enhancing Quality Through Training
Ensuring the quality and safety of drug products is crucial and can only be achieved when all personnel involved...
Read More5 December 2024
Solving the AAV scalability challenge
Gene to GMP AAV manufacturing partner, Ascend, made a presentation at ESACT about leveraging technology to build a flexible...
Read More14 October 2024
Tech Transfer Considerations
Successful technology transfer is an essential component of the gene therapy development process, as most gene therapy companies rely...
Read More4 October 2024
Contractors Support Material Testing
Testing of materials used in the manufacture and formulation of drug products is essential to ensure they meet quality...
Read More3 October 2024
Quality from the start: designing a scalable AAV production platform
Scaling of adeno-associated viral (AAV) vector manufacturing processes continues to present numerous challenges to the advance of gene therapy...
Read More24 September 2024
The Logistics of Developing an Emerging Therapy
Developing emerging modalities such as cell and gene therapies presents many challenges from selecting the right approach to overcoming...
Read More17 September 2024
Building Reliability into Scale-Up: Targeted Optimization for AAV Production
Webinar with Sartorius Stedim Biotech Scaling up AAV production presents challenges that impact performance and product quality. In this...
Read More5 September 2024
It’s All About the Small Things
The quality of final drug products correlates directly with the quality of the raw materials, APIs, excipients, and manufacturing...
Read More13 August 2024
Alliance for Regenerative Medicine (ARM) list of approved regenerative medicines
In 2024, we have more diversity in drug modalities than ever before. While small molecule and large molecule medicines...
Read More7 August 2024
How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?
Industry experts were asked to weigh in on how companies can help to keep innovation and access open. Jason...
Read More5 August 2024
Contracting Out Frees Sponsors Up
Contract manufacturing organizations (CMOs), contract development and manufacturing organizations (CDMOs), and other contract organizations offer sponsor companies flexibility by...
Read More